Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

International drug pricing index plan sent to White House

HHS has sent its proposal to base certain drug prices on an international index to the White House last week, according to a report from The Hill.

Thumbnail

Drugmakers to merge in $63B deal

Two major, global pharmaceutical companies ––AbbVie and Allergan––are merging in a deal worth approximately $63 billion.

Thumbnail

Trump order will require hospitals, insurers to disclose prices

President Trump's new executive order will enable HHS to require hospitals and insurers to disclose negotiated rates for healthcare services and give patients their out-of-pocket costs before their procedures, according to CNBC.

Thumbnail

Medicaid work requirements aren’t boosting employment in Arkansas

Arkansas, the first state to implement work requirements for certain Medicaid beneficiaries, isn’t seeing the promised benefit of increased employment as a result of the new rules, according to a recent report from The Commonwealth Fund.

 

Thumbnail

Repeal of ACA would leave 20M more uninsured

Repealing the Affordable Care Act would have serious, immediate consequences, according to the Urban Institute, including 20 million more uninsured people.

Thumbnail

WSJ: Trump to draw executive order on healthcare prices

President Trump is planning to issue an executive order that will “compel the disclosure” of healthcare prices, according to The Wall Street Journal, which cited people familiar with the matter.

Thumbnail

Not-for-profit hospitals act like corporate titans but don’t pay taxes

Not-for-profit hospitals don’t pay taxes, but many of them act like Fortune 500 companies, taking on operations that mimic corporate giants.

Thumbnail

MITA backs provisional coverage of FDA-approved tech at HHS meeting

“New technologies that are approved by the FDA but not reimbursed by CMS face a classic ‘Catch 22’,” said Mark Carol, MD, chair of MITA’s Focused Ultrasound Section.